Abstract
Using some solutions activated by irradiation with non-thermal atmospheric pressure plasma (NTAPP), we had discovered that a new and distinctive mode of cell death, named spoptosis, exists in cells, the induction of which involves the action of reactive oxygen species (ROS). However, it was unknown what types of ROS and how they trigger the cell death. When cells were treated with a higher dose of Ascorbic acid (AA) generating O2− and H2O2 or Antimycin A (AM) generating O2−, cell death occurred along with cellular shrinkage, Pdcd4 disappearance, and vesicle formation. Only in cells treated with AA, genomic DNA was digested irregularly and membrane permeability increased aberrantly. On the other hand, cells treated with a higher dose of H2O2 displayed cell death and cellular shrinkage but not the other events, and those treated with a lower dose of H2O2 displayed cell death but not the other events. Strikingly, when cells underwent double treatment with AM and H2O2, the events, which had not been observed by their single treatment, became compensated. All the events were suppressed with an antioxidant, confirming that they were mediated by ROS. Thus, the mode of cell death induced by AA or combination of AM and H2O2 was consistent with that of cell death by NTAPP-activated solutions. These results suggested that O2− and H2O2 collaboratively trigger spoptotic cell death with the associated events, and that AA and combination of AM and H2O2 are functionally alternative in place of NTAPP-activated solutions.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.